ScholarWorks@SOONCHUNHYANG UNIVERSITY: Jang, Jae Young

Detailed Information

Jang, Jae Young (장재영)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

hepatocellular carcinoma:7||Carcinoma:6||Diagnosis:6||hepatocellular:6||Hepatocellular carcinoma:6||Liver cirrhosis:5||Cirrhosis:5||Prognosis:4||liver cirrhosis:4||chronic hepatitis B:4||Chronic hepatitis C:4||Endosonography:3||Elasticity imaging techniques:3||hepatitis B:3||transient elastography:3||의약학:3||prognosis:3||Autoimmune hepatitis:2||Varices:2||cystatin C:2||nutrition:2||Drug resistance:2||Hepatitis B virus:2||Endoscopic variceal ligation:2||Recurrence:2||Mortality:2||Hepatitis C virus:2||Gastroesophageal varices:2||Nephrotoxicity:2||risk prediction:2||Tenofovir:2||antiviral therapy:2||survival:2||hepatitis B virus:2||tenofovir:2||ascites:2||Alcoholic hepatitis:2||Nonselective βblocker:2||Toxic hepatitis:2||Chemoembolization:2||Esophageal and gastric varices:2||Ultrasonography:2||소화기내과:2||Variceal bleeding:2||Drug Resistance:1||Drug induced autoimmune hepatitis:1||Druginduced Liver Injury:1||Druginduced liver injury:1||Dysplasia:1||Ecklonia stolonifera extract:1||Effectiveness:1||Elastography:1||Embolization:1||Endoscopic retrograde cholangiopancreatography:1||Endoscopy:1||Entecavir:1||Enteral nutrition:1||Epidemiology:1||Esophageal adenocarcinoma:1||Esophageal varices:1||Etiology:1||Extrahepatic metastases:1||F18fluorodeoxyglucose positron emission tomography/computed tomography scan:1||Fatty liver:1||Fecal calprotectin:1||Feeding artery:1||Feeding methods:1||Fexuprazan:1||Fluorodeoxyglucose F18:1||Focal liver lesions (FLLs):1||Fundal varices:1||Gastric variceal bleeding:1||Gastric varices:1||Gastric varix:1||Gastritis:1||Gastrointestinal hemorrhage:1||Glomerular Filtration Rate:1||Glucosamine:1||Guideline:1||Guidelines:1||HBV DNA:1||HBV DNA redetection:1||HBV prophylaxis:1||HBV reactivation:1||HBV reverse transcription:1||HBsAg:1||HCVHIV coinfection:1||HVPG:1||Handfoot skin reaction:1||Health functional food:1||Health policy:1||Hematochezia:1||Hemodynamics:1||Hemorrhage:1||Hepatic encephalopathy:1||Hepatic function:1||Hepatic venous pressure gradient:1||Hepatic venous pressure gradient (HVPG):1||Hepatitis:1||Hepatitis B:1||Hepatitis B, Chronic:1||Hepatitis C:1||Hepatocellular:1||Hepatopulmonary syndrome:1||Hepatotoxicity:1||Histoacryl:1||Histoacryl (R) (Nbutyl2cyanoacrylate):1||Histoacryl (R) injection:1||Hypertension, Portal:1||Hypertension, portal:1||Ileus:1||Insulin resistance:1||Interferonα2b:1||Jejunal Varices:1||Key Words:1||Klebsiella pneumoniae:1||Koreans:1||Lamivudine:1||Lamivudine resistance:1||Legal liabilities:1||Lipid metabolism:1||Lipopolysaccharide:1||Liver Cirrhosis:1||Liver fibrosis:1||Liver injury:1||Liver masses:1||Liver stiffness:1||Magnifying endoscopy:1||Management:1||Medical errors:1||Methylene blue chromoendoscopy:1||Molecular:1||Muscle mass:1||Mutation:1||N&#8208:1||Neutrophil to lymphocyte ratio:1||Noninferiority trial:1||Occult infection:1||Orthopedics:1||Overestimation:1||Overlap syndrome:1||PIVKAII:1||Pancreas:1||Pathology:1||Patient safety:1||Pegylated interferon alpha2b:1||Pentoxifylline:1||Phase III clinical trial:1||Plants, Medicinal:1||Platelet:1||Platelet to lymphocyte ratio:1||Portal Hypertension:1||Portal vein:1||Portal vein invasion:1||Portasystemic shunt, surgical:1||Positronemission tomography:1||Potassiumcompetitive acid blocker:1||Predictor:1||Prescribed Medicines:1||Primary biliary cirrhosis:1||Prognostic factors:1||Prophylaxis:1||RNA methylation:1||ROC curve:1||Radiationinduced liver disease:1||Real time shear wave elastography:1||Realtime elastography:1||Realworld study:1||Rebleeding:1||Relation of Fibroblast Growth Factor Receptor 2 Expression to Hepatocellular Carcinoma Recurrence After Liver Resection:1||Relative adrenal insufficiency in chronic liver disease: itsprevalence and effects on longterm mortality:1||Renal Function:1||Restriction fragment mass polymorphism:1||Review:1||Ribavirin:1||Risk factors:1||Safety:1||Scoring system:1||Secondary prevention:1||Sequential organ failure assessment:1||Serum Creatinine Level:1||Sex:1||Shear wave elastography:1||Shortsegment:1||Sorafenib:1||Specialized intestinal metaplasia:1||Splenomegaly:1||Spontaneous Bacterial Peritonitis:1||Stereotactic body radiation therapy:1||Superior mesenteric artery syndrome:1||Surveillance:1||Survival:1||Sustained virologic response:1||Sustained virological response:1||TRAIL Enhances Apoptosis of Human HepatocellularCarcinoma Cells Sensitized by Hepatitis C Virus Infection:Therapeutic Implications:1||TRAIL receptor:1||Therapeutic:1||Therapeutics:1||Thrombosis:1||Tomography:1||Traditional Therapy:1||Transarterial chemoembolization:1||Transient elastography:1||Treatment:1||Treatment of gastric varix:1||Tumor size:1||Urea cream:1||Variceal hemorrhage:1||Vascular endothelial growth factor:1||Virologic response:1||Virology:1||VogtKoyanagiHarada disease:1||Xray computed:1||acetyl&#8208:1||acute decompensation:1||acuteonchronic liver failure:1||alcoholic hepatitis:1||alternative treatment:1||amino acids:1||antivirals:1||associated lipocalin:1||beta blocker:1||branchedchain:1||branchedchain amino acid:1||cACLD:1||carcinoma:1||chemoembolization:1||chemotherapy:1||chronic:1||chronic liver failure:1||colon cancer:1||colonoscopy:1||combination therapy:1||complication:1||creatinine:1||decompensated cirrhosis:1||diabetes mellitus:1||diagnostic value:1||directacting antivirals:1||eGFR:1||endoscopic variceal ligation:1||enhanced ultrasonography:1||epsilon loop:1||fatty liver:1||health education:1||hepatic arterial infusion chemotherapy:1||hepatic encephalopathy:1||hepatitis B e antigen:1||hepatocellular carcinoma.:1||hepatorenal syndrome:1||high cost:1||hyperlipidemia:1||immunosuppressant:1||incidence:1||inflammation:1||kidney injury:1||lamivudine:1||liver biopsy:1||liver transplantation:1||lowMELD:1||molecular target agents:1||mortality:1||multidrug resistance:1||neutrophil gelatinase&#8208:1||nonHodgkin lymphoma:1||nonalcoholic fatty liver disease:1||nutrition education:1||platelet:1||prophylaxis:1||pyogenic liver abscess:1||radiofrequency ablation:1||reactivation:1||refractoriness:1||renal dysfunction:1||renal insufficiency:1||risk factor:1||rituximab:1||sorafenib:1||spleen:1||stereotactic body radiotherapy:1||survival rate:1||tamoxifen:1||therapeutic:1||therapy:1||transarterial chemoembolization:1||treatment:1||ulcerative:1||validation:1||varices:1||간경변:1||경관급식:1||글루코사민:1||내시경 정맥류 결찰술:1||독성 간염:1||독성간염:1||문헌고찰:1||바이러스반응:1||비선택적 베타차단제:1||식도위정맥류:1||약제 내성:1||약제유발성 자가면역 간염:1||영양액 주입방법:1||예후인자:1||위식도정맥류:1||위장관출혈:1||자가면역 간염:1||자가면역간염:1||조직병리학:1||진단:1||치료:1||테노포비어:1||&#8208:1||한국:1||&#946:1||2DSWE:1||AFP:1||AFPL3:1||Abdominal Computed Tomography:1||Acousticradiationforce impulse elastography:1||Acuteon:1||Acuteonchronic liver failure:1||Acyclic Nucleotide Phosphonate:1||Adefovir:1||Adrenal abscesses:1||Alcoholic liver disease:1||Antiviral drug resistance:1||Apoptosis:1||Autoimmune:1||Bacterial translocation:1||Band ligation:1||Barrett's esophagus:1||Baveno VI:1||Besifovir:1||Betablocker:1||Biomarkers:1||Blood platelets:1||Body mass index:1||Bone mineral density:1||B형간염:1||Capsule Endoscopy:1||Carcinoma, hepatocellular:1||ChildPugh score:1||Chronic Hepatitis B:1||Chronic hepatitis:1||Circulating tumor DNA:1||Cohort:1||Colitis:1||Complete response:1||Contrast:1||Contrast enhanced Ultrasonography (CEUS):1||Contrast enhanced ultrasonography:1||Corticosteroid:1||Criteria:1||Cyanoacrylate:1||Cyclooxygenase2:1||D glucosaminidase:1||

STATISTICS: Total View :1,202,635; Today View :3,295

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE